- Previous Close
40,500.00 - Open
0.00 - Bid --
- Ask --
- Day's Range
0.00 - 0.00 - 52 Week Range
0.00 - 62,900.00 - Volume
0 - Avg. Volume
27,260 - Market Cap (intraday)
676.86B - Beta (5Y Monthly) 1.00
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 12, 2025 - May 16, 2025
- Forward Dividend & Yield 650.00 (1.60%)
- Ex-Dividend Date Aug 8, 2024
- 1y Target Est
63,000.00
SK Chemicals Co.,Ltd provides chemicals and life sciences products and solutions in South Korea, China, Japan, Asia, the United States, Europe, and internationally. The company offers copolyester, engineering plastic, petro chemical, specialty chemical, coating and adhesive, biomaterial, and performance chemical for covid-19 personal protective equipment, industrial materials, sustainable packaging solution, packaging, cosmetic, automotive, consumer goods and sports, and electronics and home appliance applications. It sells its products under the SKYGREEN, SKYPEL, SKYBON, ECOZEN, SKYTRA, ECOTRION, CLARO, SKYDMT, CnR, ECOTRIA, SKYCHDM, E.Chemical, SKYPET, SKYDMCD, SKYPURA, and SKYCHDA brands. The company provides ETC drugs, including musculoskeletal system, anti-inflammatory agents/analgenics, digestive system, central nervous system, respiratory system, urinary system, kidney/rheumatism, circulatory system/metabolic disease, antimicrobial/antiviral agents, and others; OTC drugs, such as common cold/antihistamine, drugs to improve blood flow, vitamins/minerals, dermatologicals, and other products. The company was founded in 1969 and is headquartered in Seongnam-si, South Korea.
www.skchemicals.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 285130.KS
View More
Performance Overview: 285130.KS
Trailing total returns as of 3/31/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 285130.KS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 285130.KS
View MoreValuation Measures
Market Cap
697.53B
Enterprise Value
972.43B
Trailing P/E
108.00
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.55
Price/Book (mrq)
0.35
Enterprise Value/Revenue
0.56
Enterprise Value/EBITDA
6.50
Financial Highlights
Profitability and Income Statement
Profit Margin
0.51%
Return on Assets (ttm)
-0.59%
Return on Equity (ttm)
-0.15%
Revenue (ttm)
1.74T
Net Income Avi to Common (ttm)
8.84B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
1.39T
Total Debt/Equity (mrq)
54.67%
Levered Free Cash Flow (ttm)
-568.79B